CN101850034B - Chinese medicament for treating angina - Google Patents
Chinese medicament for treating angina Download PDFInfo
- Publication number
- CN101850034B CN101850034B CN2009102383591A CN200910238359A CN101850034B CN 101850034 B CN101850034 B CN 101850034B CN 2009102383591 A CN2009102383591 A CN 2009102383591A CN 200910238359 A CN200910238359 A CN 200910238359A CN 101850034 B CN101850034 B CN 101850034B
- Authority
- CN
- China
- Prior art keywords
- chinese
- chinese medicine
- radix
- fine powder
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating angina, and belongs to the field of Chinese medicaments for treating cardiovascular and cerebrovascular system diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as Chinese eaglewood, radix pseudo-ginseng, Chinese angelica, radix rehmanniae preparata and glossy ganoderma. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis and regulating vital energy and stopping pain, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Present be intended to treat the anginal field of Chinese medicines, exist some problems: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many patient with angina pectoris are subjected to the torment of feeling of oppression and pain in the chest for a long time, the probability that myocardial infarction takes place increases, and has influenced life quality.
At problem set forth above, the invention provides the anginal Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the anginal Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Lignum Aquilariae Resinatum 4--30 part Radix Notoginseng 3--20 part Radix Angelicae Sinensis 4--30 part
Radix Rehmanniae Preparata 4--30 part Ganoderma 2--12 part
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, Radix Rehmanniae Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae Preparata the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, tranquilizing by nourishing the heart, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic, coronary artery dilating, coronary blood flow increasing; Be aided with Lignum Aquilariae Resinatum virtue turbid, the regulating QI to relieve pain that reduces phlegm.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of regulating QI to relieve pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Lignum Aquilariae Resinatum 80 gram Radix Notoginseng 60 gram Radix Angelicae Sinensis 80 grams
Radix Rehmanniae Preparata 70 kairine sesames 40 grams
Weight in accordance with regulations, with conventional water extraction process Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, Radix Rehmanniae Preparata are extracted, make extractum fine powder 72 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 614 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Lignum Aquilariae Resinatum 160 gram Radix Notoginseng 100 gram Radix Angelicae Sinensis 160 grams
Radix Rehmanniae Preparata 160 kairine sesames 60 grams
By above-mentioned same method, make 1085 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Lignum Aquilariae Resinatum 300 gram Radix Notoginseng 200 gram Radix Angelicae Sinensis 300 grams
Radix Rehmanniae Preparata 300 kairine sesames 120 grams
By above-mentioned same method, make 2107 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 4 parts of Radix Angelicae Sinensis of 7 portions of Radix Notoginseng of Lignum Aquilariae Resinatum
3 parts of 7 portions of Ganodermas of Radix Rehmanniae Preparata
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 15 parts of Radix Angelicae Sinensis of 25 portions of Radix Notoginseng of Lignum Aquilariae Resinatum
7 parts of 25 portions of Ganodermas of Radix Rehmanniae Preparata
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science angina pectoris, through 7 routine clinical observations.Selecting the tcm diagnosis angina pectoris is standard: feeling of oppression and pain in the chest, and nervous cardiopalmus, limbs fatigue, the visible T ripple of electrocardiogram is unusual during outbreak.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 51 years old-82 years old, 66.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and heart district is comfortable, and angor uncomfortable in chest is obviously alleviated or disappeared, and Electrocardioscopy is no abnormal.
2, effective: body constitution strengthens to some extent, and angor uncomfortable in chest is alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. the anginal Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Lignum Aquilariae Resinatum 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 4---
12 parts of Radix Rehmanniae Preparata 4---30 portions of Ganodermas 2---
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, Radix Rehmanniae Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102383591A CN101850034B (en) | 2009-11-25 | 2009-11-25 | Chinese medicament for treating angina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102383591A CN101850034B (en) | 2009-11-25 | 2009-11-25 | Chinese medicament for treating angina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850034A CN101850034A (en) | 2010-10-06 |
| CN101850034B true CN101850034B (en) | 2011-08-10 |
Family
ID=42801824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102383591A Expired - Fee Related CN101850034B (en) | 2009-11-25 | 2009-11-25 | Chinese medicament for treating angina |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850034B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1376491A (en) * | 2002-04-15 | 2002-10-30 | 徐国勇 | Medicine for treating myocardial infarction and angina pectoris |
-
2009
- 2009-11-25 CN CN2009102383591A patent/CN101850034B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1376491A (en) * | 2002-04-15 | 2002-10-30 | 徐国勇 | Medicine for treating myocardial infarction and angina pectoris |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850034A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101554443B (en) | Traditional Chinese medicine for treating angina | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101850034B (en) | Chinese medicament for treating angina | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843759B (en) | Oral Chinese medicament for treating fracture | |
| CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843647B (en) | Chinese medicament for treating angina | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101850083B (en) | Chinese medicament for treating asthma | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843792A (en) | Chinese medicament for treating angina | |
| CN101897808A (en) | Traditional Chinese medicine for treating angina pectoris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO JUNZHANG ELECTRONICS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: Zhu Yao Cun Bai Pu Zhen 226500 Jiangsu city of Rugao Province in 18 groups Patentee after: Rugao Jun Zhang Electronics Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20171125 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |